Alnylam Pharmaceuticals reported $98.09M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 12.75M 2.74M
Agios Pharmaceuticals AGIO:US USD 18.62M 8.2M
Alnylam Pharmaceuticals ALNY:US USD 98.09M 57.52M
Arrowhead Research ARWR:US USD 796K 2.07M
Avrobio Inc AVRO:US USD 384K 1.43M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Intercept Pharmaceuticals ICPT:US USD 14.23M 7.07M
Mirati Therapeutics MRTX:US USD 38.86M 19.41M
Moderna Inc MRNA:US USD 487M 157M
Novartis NVS:US USD 5.15B 453M
Ptc Therapeutics PTCT:US USD 27.27M 6.41M
Regulus Therapeutics RGLS:US USD 175K 621K
Sangamo Biosciences SGMO:US USD 22.42M 5.04M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Takeda 4502:JP JPY 381.11B 7.51B
Ultragenyx Pharmaceutical RARE:US USD 43.27M 19.74M
Xencor XNCR:US USD 10.09M 4.53M
YTE INCY:US USD 277.55M 114.37M